.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Uncover prior art in expired and abandoned patents
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Farmers Insurance
Baxter
Colorcon
Accenture
Queensland Health
Fish and Richardson
Julphar
Federal Trade Commission
Teva

Generated: July 21, 2017

DrugPatentWatch Database Preview

Magnesium chloride; sodium bicarbonate; sodium chloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for magnesium chloride; sodium bicarbonate; sodium chloride and what is the scope of magnesium chloride; sodium bicarbonate; sodium chloride patent protection?

Magnesium chloride; sodium bicarbonate; sodium chloride
is the generic ingredient in two branded drugs marketed by Dialysis Sups and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Magnesium chloride; sodium bicarbonate; sodium chloride has four patent family members in four countries.

There are one hundred and thirty-two drug master file entries for magnesium chloride; sodium bicarbonate; sodium chloride.

Summary for Generic Name: magnesium chloride; sodium bicarbonate; sodium chloride

Tradenames:2
Patents:2
Applicants:1
NDAs:1
Drug Master File Entries: see list132
Clinical Trials: see list2,954
Drug Prices:see low prices
DailyMed Link:magnesium chloride; sodium bicarbonate; sodium chloride at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dialysis Sups
NORMOCARB HF 25
magnesium chloride; sodium bicarbonate; sodium chloride
SOLUTION;INJECTION021910-001Jul 26, 2006RXYesYes5,945,449► SubscribeY ► Subscribe
Dialysis Sups
NORMOCARB HF 25
magnesium chloride; sodium bicarbonate; sodium chloride
SOLUTION;INJECTION021910-001Jul 26, 2006RXYesYes7,300,674► SubscribeY ► Subscribe
Dialysis Sups
NORMOCARB HF 35
magnesium chloride; sodium bicarbonate; sodium chloride
SOLUTION;INJECTION021910-002Jul 26, 2006RXYesYes5,945,449► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: magnesium chloride; sodium bicarbonate; sodium chloride

Country Document Number Estimated Expiration
European Patent Office1347795► Subscribe
World Intellectual Property Organization (WIPO)0249693► Subscribe
Australia2620902► Subscribe
Canada2365787► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: MAGNESIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB01/006United Kingdom► SubscribePRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
12/048Ireland► SubscribePRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812
00517Netherlands► SubscribePRODUCT NAME: ACETYLSALICYLZUUR EN ESOMEPRAZOLMAGNESIUMTRIHYDRAAT; NAT. REGISTRATION NO/DATE: RVG 107516 20110912; FIRST REGISTRATION: 540235954023675402375 2011120812
00482Netherlands► SubscribePRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMZOUT; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17091/0263 - 0001 20101105
0483Netherlands► SubscribePRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYDRAAT; NATIONAL REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: GB PL 17091/0263 - 0001 20101105
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Julphar
Merck
Cerilliant
Johnson and Johnson
Dow
Novartis
Chubb
Argus Health
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot